These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3945939)

  • 1. Teratogen metabolism: thalidomide activation is mediated by cytochrome P-450.
    Braun AG; Harding FA; Weinreb SL
    Toxicol Appl Pharmacol; 1986 Jan; 82(1):175-9. PubMed ID: 3945939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes and involvement of cytochrome P-450 in dehydrogenation of lovastatin.
    Vyas KP; Kari PH; Prakash SR; Duggan DE
    Drug Metab Dispos; 1990; 18(2):218-22. PubMed ID: 1971576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide metabolism by the CYP2C subfamily.
    Ando Y; Fuse E; Figg WD
    Clin Cancer Res; 2002 Jun; 8(6):1964-73. PubMed ID: 12060642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation of phenol to hydroquinone and catechol by rat liver microsomes.
    Sawahata T; Neal RA
    Mol Pharmacol; 1983 Mar; 23(2):453-60. PubMed ID: 6835203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation of glyceryl trinitrate by rat aortic cytochrome P450.
    McDonald BJ; Bennett BM
    Biochem Pharmacol; 1993 Jan; 45(1):268-70. PubMed ID: 8424819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teratogen metabolism: activation of thalidomide and thalidomide analogues to products that inhibit the attachment of cells to concanavalin A coated plastic surfaces.
    Braun AG; Weinreb SL
    Biochem Pharmacol; 1984 May; 33(9):1471-7. PubMed ID: 6732864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactivation of carbon tetrachloride, chloroform and bromotrichloromethane: role of cytochrome P-450.
    Sipes IG; Krishna G; Gillette JR
    Life Sci; 1977 May; 20(9):1541-8. PubMed ID: 17803
    [No Abstract]   [Full Text] [Related]  

  • 8. Chloroethanes : their metabolism by hepatic cytochrome P-450 in vitro.
    Ivanetich KM; Van den Honert LH
    Carcinogenesis; 1981; 2(8):697-702. PubMed ID: 7285278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of hepatic cytochrome P450 systems to the generation of reactive oxygen species.
    Bondy SC; Naderi S
    Biochem Pharmacol; 1994 Jul; 48(1):155-9. PubMed ID: 8043018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic activation of lidocaine and covalent binding to rat liver microsomal protein.
    Masubuchi Y; Araki J; Narimatsu S; Suzuki T
    Biochem Pharmacol; 1992 Jun; 43(12):2551-7. PubMed ID: 1632813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The destruction of cytochrome P-450 by alclofenac: possible involvement of an epoxide metabolite.
    Brown LM; Ford-Hutchinson AW
    Biochem Pharmacol; 1982 Jan; 31(2):195-9. PubMed ID: 6120697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of carbon monoxide by cytochrome P450 during iron-dependent lipid peroxidation.
    Archakov AI; Karuzina II; Petushkova NA; Lisitsa AV; Zgoda VG
    Toxicol In Vitro; 2002 Feb; 16(1):1-10. PubMed ID: 11812634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The apparent loss of cytochrome P-450 associated with metabolic activation of carbon tetrachloride.
    Yamazoe Y; Sugiura M; Kamataki T; Kato R
    Jpn J Pharmacol; 1979 Oct; 29(5):715-21. PubMed ID: 43918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 dependent metabolism of arachidonic acid in bovine corneal epithelium.
    Schwartzman ML; Abraham NG; Masferrer J; Dunn MW; McGiff JC
    Biochem Biophys Res Commun; 1985 Oct; 132(1):343-51. PubMed ID: 3933501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between hepatic microsomal metabolism of N-nitrosamines and cytochrome P-450 species.
    Kawanishi T; Ohno Y; Takahashi A; Takanaka A; Kasuya Y; Omori Y
    Biochem Pharmacol; 1985 Apr; 34(7):919-24. PubMed ID: 3985997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of cytochrome P-450 in mixed function oxidation and metabolism of anesthetics].
    Shigematsu A; Takahashi S; Furukawa T
    Masui; 1974 Feb; 23(2):89-98. PubMed ID: 4603810
    [No Abstract]   [Full Text] [Related]  

  • 17. The metabolism of 1-phenyl-2-(N-methyl-N-furfurylamino)propane (furfenorex) in the rat in vivo and in vitro.
    Inoue T; Yasuda T; Suzuki S; Kishi T; Niwaguchi T
    Xenobiotica; 1986 Feb; 16(2):109-21. PubMed ID: 3962333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of the "mixed" cytochrome P-450 inducer hexachlorobenzene by rat liver microsomes.
    Stewart FP; Smith AG
    Biochem Pharmacol; 1986 Jul; 35(13):2163-70. PubMed ID: 3729973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a predominantly NADH-dependent O-dealkylating system in rat hepatic microsomes.
    Kuwahara S; Mannering GJ
    Biochem Pharmacol; 1985 Dec; 34(24):4215-28. PubMed ID: 3935115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of dihalomethanes to carbon monoxide. II. In vitro studies.
    Kubic VL; Anders MW
    Drug Metab Dispos; 1975; 3(2):104-12. PubMed ID: 236156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.